ARCHIVES

Phase III BETH Study Combining Avastin And Herceptin Open For Enrollment

This article is from The Cancer Letter archive.

Vol. 31 No. 6 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Waxman urges drug companies to list clinical trials on NIH Web site.

June 18, 2004

Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds

October 31, 2003

ADT May Increase Risk Of Cardio Events In Prostate Cancer Patients

February 5, 2010

Half of New NCI Funds in FY02 Spent on Grants

November 22, 2002

Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment

February 7, 2014

NCI Programs: U.S., U.K., Ireland Established Consortium For Cancer Research

October 15, 1999